LONDON--(BUSINESS WIRE)--The global human respiratory syncytial virus drugs market is expected to grow at a CAGR of more than 4% during the forecast period, according to Technavio’s latest report.

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

Respiratory syncytial virus (RSV), originally recovered from a colony of chimpanzees with coryza and designated chimpanzee coryza agent, 1,2 and human parainfluenza virus types 1, 2, 3 ...

The Business Research Company's Human Respiratory Syncytial Virus Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest ...

Respiratory syncytial virus (RSV ... This phase 2a, randomized, double-blind, placebo-controlled, human virus challenge trial was conducted in two parts. In part 1, the trial was powered to ...

Researchers have developed a new antiviral strategy to fight human respiratory syncytial virus (RSV), a leading cause of lower respiratory tract infections in children. The approach hinges on the ...

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory ...

with acute respiratory infections attributable to human metapneumovirus (HMPV), respiratory syncytial virus (RSV), or both in May and June 2002. Fifty-three (48%) children were infected with RSV ...

A new study has shown that human T cells have an important role to play in controlling infection. Respiratory Syncytial Virus (RSV) is a highly contagious and seasonal respiratory virus that ...

Health officials reported that cases of human metapneumovirus (HMPV) spiked this spring as COVID-19 and Respiratory Syncytial Virus cases fell. National data from the Centers for Disease Control ...